- Home
- RMCF vs POAI Comparison
RMCF vs POAI Comparison
Compare RMCF & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMCF
- POAI
- Stock Information
- Founded
- RMCF 1981
- POAI 2002
- Country
- RMCF United States
- POAI United States
- Employees
- RMCF N/A
- POAI N/A
- Industry
- RMCF Specialty Foods
- POAI Industrial Specialties
- Sector
- RMCF Consumer Staples
- POAI Health Care
- Exchange
- RMCF Nasdaq
- POAI Nasdaq
- Market Cap
- RMCF 9.4M
- POAI 7.6M
- IPO Year
- RMCF N/A
- POAI N/A
- Fundamental
- Price
- RMCF $1.66
- POAI $0.76
- Analyst Decision
- RMCF
- POAI Hold
- Analyst Count
- RMCF 0
- POAI 1
- Target Price
- RMCF N/A
- POAI N/A
- AVG Volume (30 Days)
- RMCF 57.0K
- POAI 220.6K
- Earning Date
- RMCF 07-15-2025
- POAI 08-12-2025
- Dividend Yield
- RMCF N/A
- POAI N/A
- EPS Growth
- RMCF N/A
- POAI N/A
- EPS
- RMCF N/A
- POAI N/A
- Revenue
- RMCF $29,545,000.00
- POAI $1,729,269.00
- Revenue This Year
- RMCF N/A
- POAI $486.27
- Revenue Next Year
- RMCF N/A
- POAI $65.50
- P/E Ratio
- RMCF N/A
- POAI N/A
- Revenue Growth
- RMCF 5.81
- POAI 24.17
- 52 Week Low
- RMCF $1.12
- POAI $0.55
- 52 Week High
- RMCF $3.49
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- RMCF 48.22
- POAI 32.58
- Support Level
- RMCF $1.73
- POAI $0.76
- Resistance Level
- RMCF $2.07
- POAI $0.81
- Average True Range (ATR)
- RMCF 0.19
- POAI 0.04
- MACD
- RMCF -0.04
- POAI 0.00
- Stochastic Oscillator
- RMCF 1.67
- POAI 16.44
About RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, U-Swirl Operations, and Other t. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.